EcoDrugPlus

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSGACG00000004157
Gene Symbol: YES1
2 Cross references
197 Possible Orthologues:

Acetylcholinesterase

Ensembl ID : ENSGACG00000000728
Gene Symbol: ACHE
1 Cross references
233 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSGACG00000016690
Gene Symbol: ACVR2B
1 Cross references
196 Possible Orthologues:

Activin A Receptor Type 2ba

Ensembl ID : ENSGACG00000018107
Gene Symbol: ACVR2BA
1 Cross references
194 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSGACG00000000302
Gene Symbol: ADORA1
1 Cross references
208 Possible Orthologues:

Adenosine A1 Receptor B

Ensembl ID : ENSGACG00000008072
Gene Symbol: ADORA1B
1 Cross references
201 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSGACG00000017534
Gene Symbol: ADORA2A
1 Cross references
200 Possible Orthologues:

Adenosine A2a Receptor A

Ensembl ID : ENSGACG00000013408
Gene Symbol: ADORA2AA
1 Cross references
188 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSGACG00000020262
Gene Symbol: ADORA2B
1 Cross references
199 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSGACG00000005160
Gene Symbol: ADORA3
1 Cross references
235 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSGACG00000005499
Gene Symbol: ADORA3
1 Cross references
235 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSGACG00000011456
Gene Symbol: ADA
1 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).